Skip to content

FDA orders Juul Labs to remove e-cigs from market

"As a result, the company must stop selling and distributing these products. In addition, those currently on the U.S. market must be removed, or risk enforcement action," the FDA said on Thursday.
4_3-Homepage_All_Devices-US-Desktop_2x

Bad news for E-cigarettes smokers, as the FDA orders the end of JUUL products from selling in the U.S. market. 

The move was confirmed on Thursday by the agency, announcing that they have rejected from JUUL company to sell tobacco and menthol products. 

"As a result, the company must stop selling and distributing these products. In addition, those currently on the U.S. market must be removed, or risk enforcement action," the FDA said early on Thursday.

The agency rejected the company's application due to the fact that JUUL did not provide sufficient evidence to analyze potential risk of toxicity in the company's products. 

Every company that sells electric cigarettes and vaping products are required to get cleared by the FDA before becoming officially marketable and sold. 

"This action by FDA reflects the agency's steadfast commitment to carefully evaluating the science to ensure that only those products meeting its rigorous public health standards are granted marketing authorization. FDA has taken the proper steps to protect the health of all Americans," US Health and Human Services Secretary Xavier Becerra stated on Thursday.

Michele Mital, acting director of the FDA's Center for Tobacco Products, says that the agency is taking action on the matter to ensure safety for those who purchase such products from companies that they approve of, which JUUL failed to fulfill based on their qualifications. 

"The FDA is tasked with ensuring that tobacco products sold in this country meet the standard set by the law, but the responsibility to demonstrate that a product meets those standards ultimately falls on the shoulders of the company," said Michele Mital, acting director of the FDA's Center for Tobacco Products. "As with all manufacturers, JUUL had the opportunity to provide evidence demonstrating that the marketing of their products meets these standards. However, the company did not provide that evidence and instead left us with significant questions. Without the data needed to determine relevant health risks, the FDA is issuing these marketing denial orders."